To Estimate the Potential Effects of Repeat Doses of Darapladib on the Pharmacokinetics (PK) of Rosuvastatin as Well as Evaluating Safety and Tolerability in Healthy Volunteers
Clinical trial NCT01751074 · COMPLETED
Trial details
- NCT number
- NCT01751074
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-17
- Primary completion
- 2013-03-14
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.